| FTHAX | NAESX | FTHAX / NAESX | |
| Total Expense Ratio | 1.04 | 0.17 | 612% |
| Annual Report Gross Expense Ratio | 1.04 | 0.17 | 612% |
| Fund Existence | 7 years | 65 years | - |
| Gain YTD | 6.560 | 2.409 | 272% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.8B | 162B | 7% |
| Annual Yield % from dividends | 0.43 | 1.22 | 35% |
| Returns for 1 year | -5.65 | -0.86 | 661% |
| Returns for 3 years | 34.85 | 29.99 | 116% |
| Returns for 5 years | 75.21 | 39.31 | 191% |
| Returns for 10 years | N/A | 122.07 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VTEI | 100.78 | -0.09 | -0.09% |
| Vanguard Intermediate-Term Tx-Exm Bd ETF | |||
| PICB | 23.36 | -0.14 | -0.62% |
| Invesco International Corporate Bond ETF | |||
| GNOM | 42.54 | -0.51 | -1.18% |
| Global X Genomics & Biotechnology ETF | |||
| TRIO | 64.81 | -0.94 | -1.43% |
| MC Trio Equity Buffered ETF | |||
| HERZ | 2.52 | -0.05 | -1.95% |
| Herzfeld Credit Income Fund Inc | |||